| HISAMITSU PHARMA. |
| Japan |
| Gesundheit |
| JP3784600003 / 864341 |
| HPX (Frankfurt) |
| FRA:HPX, ETR:HPX, HPX:GR |
| - |
| http://www.hisamitsu.co.j.. |
|
Hisamitsu Pharmaceutical Co., Inc. is a distinguished player in the pharmaceutical industry, primarily engaged in the development, production, and distribution of therapies centered around transdermal drug delivery systems. These systems play a criti..
>Volltext.. |
| 2391.45 Mio. EUR |
| 1808.15 Mio. EUR |
| 883.46 Mio. EUR |
| 140.63 Mio. EUR |
| 110.88 Mio. EUR |
| 1.54 EUR |
| 13.08 Mio. EUR |
| 562.57 Mio. EUR |
| - |
| 2.14 |
| -7.21% |
| 12.66% |
| 0.34 EUR |
| 1.74% |
| 1.02% |
| 28.08.25 - 0.341856€ 27.02.25 - 0.256392€ >weitere anzeigen... |
| - |
| HISAMITSU |
| 05.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|